Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.63 |
| ▸ | LMNA | P02545 | 2/20 | 0.63 |
| ▸ | MAPT | P10636 | 4/20 | 0.55 |
| ▸ | ABCC4 | O15439 | 1/20 | 0.55 |
| ▸ | TSHR | P16473 | 3/20 | 0.50 |
| ▸ | DGKA | P23743 | 1/20 | 0.48 |
| ▸ | LPAR3 | Q9UBY5 | 2/20 | 0.44 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.42 |
| ▸ | USP2 | O75604 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.42 |
| ▸ | RECQL | P46063 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.41 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | THRB | P10828 | 1/20 | 0.38 |
| ▸ | CNR1 | P21554 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28520080 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL14245261 | 1.00 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL28241811 | 0.98 | ALDH1A1 (0.60) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL14956744 | 0.94 | ALDH1A1 (0.66) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL24425884 | 0.92 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL11909573 | 0.92 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL14244897 | 0.92 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL11322829 | 0.92 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL20547697 | 0.92 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR | |
| SCHEMBL11326465 | 0.92 | ALDH1A1 (0.63) | ALDH1A1LMNAMAPTABCC4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113956382-B | Curing composition and application thereof, curing resin and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-02-13 | — | — | CN | claimed |
| CN-113956477-B | Curing composition and application thereof, and cured polymer material and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-114031707-B | Cured material composition and application thereof, cured resin and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-08-15 | — | — | CN | claimed |
| CN-114031707-A | Cured material composition and application thereof, cured resin and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-02-11 | — | — | CN | claimed |
| CN-113956382-A | Curing composition and application thereof, curing resin and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-01-21 | — | — | CN | claimed |
| CN-113956477-A | Curing composition and application thereof, curing polymer material and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-01-21 | — | — | CN | claimed |
| US-6756500-B1 | SUBJECTING SUBSTITUTED ALPHA, OMEGA-DIENE IN PRESENCE OF RUTHENIUM, OSMIUM OR MOLYBDENUM HOMOGENEOUS OR HETEROGENEOUS CATALYST TO METATHESIS REACTION IN PRESENCE OF IONIC LIQUID TO FORM CYCLIC COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 2004-06-29 | — | — | US | claimed |
| EP-1035093-B1 | Metathesis in the presence of ionic liquids | BAYER AG (DE) | 2003-09-10 | — | — | EP | claimed |
| CN-113956382-B | Curing composition and application thereof, curing resin and preparation method and application thereof | 中国石油化工股份有限公司 | 2024-02-13 | — | — | CN | disclosed |
| CN-113956477-B | Curing composition and application thereof, and cured polymer material and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-10-13 | — | — | CN | disclosed |
| CN-114031707-B | Cured material composition and application thereof, cured resin and preparation method and application thereof | 中国石油化工股份有限公司 | 2023-08-15 | — | — | CN | disclosed |
| CN-114031707-A | Cured material composition and application thereof, cured resin and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-02-11 | — | — | CN | disclosed |
| CN-113956477-A | Curing composition and application thereof, curing polymer material and preparation method and application thereof | 中国石油化工股份有限公司 | 2022-01-21 | — | — | CN | disclosed |
| US-10265691-B2 | Olefin metathesis catalysts | BERGEN TEKNOLOGIOVERFORING AS (NO) | 2019-04-23 | — | — | US | disclosed |
| US-20170022231-A1 | CATALYSTS FOR (E)-SELECTIVE OLEFIN METATHESIS | CALIFORNIA INSTITUTE OF TECHNOLOGY | 2017-01-26 | — | — | US | disclosed |
| WO-2017009232-A1 | IMPROVED OLEFIN METATHESIS CATALYSTS | BERGEN TEKNOLOGIOVERFØRING AS (NO) | 2017-01-19 | — | — | WO | disclosed |
| US-20150322079-A1 | LOW CATALYST LOADING IN METATHESIS REACTIONS | EVONIK INDUSTRIES AG (DE) | 2015-11-12 | — | — | US | disclosed |
| US-20150322079-A1 | LOW CATALYST LOADING IN METATHESIS REACTIONS | EVONIK INDUSTRIES AG (DE) | 2015-11-12 | — | — | US | disclosed |
| EP-2711351-A1 | Low catalyst loading in metathesis reactions | Evonik Industries AG (DE) | 2014-03-26 | — | — | EP | disclosed |
| US-6756500-B1 | SUBJECTING SUBSTITUTED ALPHA, OMEGA-DIENE IN PRESENCE OF RUTHENIUM, OSMIUM OR MOLYBDENUM HOMOGENEOUS OR HETEROGENEOUS CATALYST TO METATHESIS REACTION IN PRESENCE OF IONIC LIQUID TO FORM CYCLIC COMPOUND | BAYER AKTIENGESELLSCHAFT (DE) | 2004-06-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170022231-A1 | CATALYSTS FOR (E)-SELECTIVE OLEFIN METATHESIS | COASY, FDFT1, SQLE | ALDH1A1 1299/4885LMNA 4006/4885MAPT 1486/4885 |
| US-10265691-B2 | Olefin metathesis catalysts | SQLE, COASY, APEX1 | ALDH1A1 809/4885LMNA 4788/4885MAPT 2959/4885 |
| US-20150322079-A1 | LOW CATALYST LOADING IN METATHESIS REACTIONS | APEX1, PMS2, MAX | ALDH1A1 2091/4885LMNA 2185/4885MAPT 3210/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.